<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">kcnh6</th>
</tr>
<tr>
<td class="label">Symbol</td>
<td><strong>KCNH6</strong></td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>kcnh6</td>
</tr>
<tr>
<td class="label">Type</td>
<td>Gene</td>
</tr>
<tr>
<td class="label">NCBI</td>
<td><a href="https://www.ncbi.nlm.nih.gov/gene/?term=KCNH6" target="_blank">Search NCBI</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>
<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">kcnh6</th>
</tr>
<tr>
<td class="label">Symbol</td>
<td><strong>KCNH6</strong></td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>kcnh6</td>
</tr>
<tr>
<td class="label">Type</td>
<td>Gene</td>
</tr>
<tr>
<td class="label">NCBI</td>
<td><a href="https://www.ncbi.nlm.nih.gov/gene/?term=KCNH6" target="_blank">Search NCBI</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>
KCNH6 (Potassium Voltage-Gated Channel Subfamily H Member 6), also known as Kv11.3 or ERG3 (Ether-à-go-go-Related Gene 3), is a member of the voltage-gated potassium channel family belonging to the KCNH (ether-à-go-go-related) subfamily. The gene is located on chromosome 17q24 (NCBI Gene ID: 27151, OMIM: 613391, UniProt: Q9H5Y9) and encodes a protein of 979 amino acids with the characteristic six-transmembrane domain structure of voltage-gated potassium channels. KCNH6 is expressed predominantly in gastrointestinal tissues and central nervous system, where it plays important roles in regulating cellular excitability. In the gastrointestinal tract, KCNH6 is highly expressed in gastric and intestinal smooth muscle, where it regulates gastric motility and intestinal peristalsis. In the brain, KCNH6 is expressed in various neuronal populations where it contributes to neuronal excitability and potentially to neurodegenerative disease processes. Unlike its close relative KCNH2 (HERG1), which is primarily known for cardiac function, KCNH6 has a distinct expression pattern and function. This comprehensive review covers KCNH6 gene structure, protein function, expression patterns, disease associations, and therapeutic implications. [@hille2001][@bauer2012]
The KCNH6 gene is located on chromosome 17q24.2 and spans approximately 15 kb of genomic DNA. The gene consists of 17 exons encoding a protein of 979 amino acids. The genomic structure includes the characteristic features of KCNH family genes, with the six transmembrane domains encoded across multiple exons. The promoter region contains elements that drive tissue-specific expression, with particular activity in gastrointestinal tissues and brain. The gene shows conservation across mammalian species, with particularly high conservation in the transmembrane domains and pore region. Alternative splicing of KCNH6 has been reported, generating multiple transcript variants with potentially different functional properties, though the significance of these variants is not fully characterized. The KCNH6 gene is part of the KCNH family that includes KCNH1 (ELK1), KCNH2 (HERG1), KCNH3 (ELK3), KCNH4 (ELK2), and KCNH5 (EAG2), each with distinct tissue distribution and function. Understanding the genomic organization of KCNH6 provides insight into its regulation and disease associations. @bauer2012
KCNH6 exhibits a distinctive tissue expression pattern with high levels in gastrointestinal tissues and lower but significant expression in the central nervous system. In the gastrointestinal tract, KCNH6 is highly expressed in gastric smooth muscle cells, where it contributes to gastric contractile activity and motility. The channel is also expressed in intestinal smooth muscle, particularly in the circular muscle layer of the small intestine and colon. In the stomach, KCNH6 is expressed in both fundus and antrum, affecting different aspects of gastric emptying and mixing. In the brain, KCNH6 shows region-specific expression. The hippocampus expresses KCNH6 in pyramidal neurons and interneurons. The cerebral cortex shows KCNH6 expression in pyramidal neurons. The cerebellum expresses KCNH6 in Purkinje cells and other neuronal types. Outside the gastrointestinal tract and brain, KCNH6 shows low expression in most other tissues, in contrast to KCNH2 which is highly expressed in the heart. The distinct expression pattern of KCNH6 reflects its specialized functions in different organ systems. @schulze2019
KCNH6 shares the structural features of the KCNH family of voltage-gated potassium channels. The protein contains:
Six transmembrane segments (S1-S6): The transmembrane domains form the voltage-sensing and pore-forming regions of the channel. S4 contains positively charged residues that confer voltage sensitivity.
Pore domain (P loop): Located between S5 and S6, the pore domain contains the selectivity filter that determines potassium selectivity.
N-terminal domain: The cytoplasmic N-terminal region contains a Per-Arnt-Sim (PAS) domain that is involved in channel gating regulation.
C-terminal domain: The cytoplasmic C-terminal region contains a cyclic nucleotide-binding homology domain (CNBHD), though KCNH6 does not bind cyclic nucleotides directly.
The overall structure allows KCNH6 to function as a voltage-gated potassium channel with characteristic gating properties. KCNH6 forms functional channels as tetramers, with four subunits coming together to form a functional pore.
KCNH6 exhibits characteristic gating properties of the KCNH family:
Voltage dependence: KCNH6 activates at relatively depolarized membrane potentials, with an activation threshold around -30 to 0 mV.
Slow activation and deactivation: KCNH6 shows relatively slow activation and deactivation kinetics compared to some other Kv channels.
Inactivation: Like other KCNH channels, KCNH6 shows C-type inactivation, a process that involves conformational changes in the selectivity filter region.
Regulation of KCNH6 includes:
KCNH6 does not function in isolation but interacts with other ion channels to regulate cellular excitability. In gastric smooth muscle, KCNH6 works in coordination with L-type calcium channels and other potassium channels to generate the characteristic patterns of electrical activity that drive motility. The interplay between KCNH6 and calcium channels is particularly important, as KCNH6-mediated repolarization limits calcium influx through voltage-gated calcium channels, thereby modulating calcium-dependent contractile activity. In neurons, KCNH6 may coordinate with other voltage-gated potassium channels including Kv1, Kv2, and Kv4 family members to shape action potential waveforms and regulate firing patterns. The specific nature of these interactions varies by cell type and physiological context. Understanding how KCNH6 integrates with other ion channels provides insight into its functional roles and suggests potential mechanisms for therapeutic modulation. @zhang2020
KCNH6 plays a crucial role in regulating gastric motility and gastric emptying. In gastric smooth muscle, KCNH6 contributes to the repolarization phase of slow waves and action potentials, affecting the frequency and force of gastric contractions.
Fundus function: In the gastric fundus, KCNH6 contributes to the relaxation that accommodates food intake and the rhythmic contractions that mix gastric contents.
Antrum function: In the gastric antrum, KCNH6 regulates the powerful contractions that grind food and empty the stomach contents into the duodenum.
Integration with pacemaker activity: Gastric smooth muscle generates rhythmic pacemaker activity that coordinates motility patterns. KCNH6 modulates the response to this pacemaker activity.
Dysregulation of KCNH6 can contribute to gastric motility disorders, including gastroparesis and functional dyspepsia. The channel represents a potential therapeutic target for gastrointestinal motility disorders. @schulze2019
KCNH6 also contributes to intestinal motility, though its role in the intestine is less well-characterized than in the stomach. Intestinal smooth muscle shows rhythmic contractions that propagate contents along the gastrointestinal tract, and KCNH6 modulates this activity.
Small intestine: KCNH6 contributes to the segmentation and peristaltic movements that mix and transport intestinal contents.
Colon: KCNH6 may play roles in colonic motility patterns, including the mass movements that empty the colon.
The gastrointestinal functions of KCNH6 make it an important target for understanding and treating digestive disorders. @bauer2012
KCNH6 plays important roles in regulating neuronal excitability in the brain, though it is less abundantly expressed in neurons compared to gastrointestinal tissues. In neurons, KCNH6 contributes to:
Action potential repolarization: KCNH6 contributes to the repolarization phase of action potentials, affecting spike shape and refractory period.
Resting membrane potential: The conductances mediated by KCNH6 contribute to setting the resting membrane potential.
Firing pattern regulation: KCNH6 modulates the firing patterns of different neuronal types.
The specific effects of KCNH6 on neuronal excitability depend on the neuronal type and the complement of other ion channels present. More research is needed to fully characterize the neuronal functions of KCNH6. @shah2018
Beyond direct effects on excitability, KCNH6 may influence synaptic function through several mechanisms. KCNH6 is expressed at some synaptic sites, where it may modulate neurotransmitter release or postsynaptic responses. The role of KCNH6 in synaptic plasticity and higher cognitive functions remains to be fully characterized.
The potential role of KCNH6 in Alzheimer's disease (AD) is an emerging area of investigation. Potassium channel dysfunction is a consistent finding in AD, with alterations in multiple potassium channel types contributing to hyperexcitability and network dysfunction.
Channel dysfunction: Studies suggest altered KCNH6 expression in some brain regions in AD models, though evidence is limited compared to other potassium channels.
Neuronal excitability: By modulating neuronal excitability, KCNH6 could potentially influence the hyperexcitability observed in AD.
Therapeutic implications: The role of KCNH6 in AD remains to be clarified, and it is not yet clear whether targeting KCNH6 would be beneficial.
More research is needed to establish the significance of KCNH6 in AD pathogenesis. @yang2019
KCNH6 may have potential relevance to Parkinson's disease (PD), though evidence is similarly limited. The expression of KCNH6 in some neuronal populations raises the possibility of involvement in PD-related processes.
Dopaminergic neurons: If KCNH6 is expressed in dopaminergic neurons of the substantia nigra, it could potentially influence their excitability and vulnerability.
Network effects: KCNH6 in other brain regions could affect basal ganglia circuit function, which is relevant to PD.
More research is needed to determine whether KCNM6 plays any significant role in PD. @song2019
Epilepsy: KCNH6 variants may contribute to seizure susceptibility in some cases, though evidence is limited.
Stroke: Following ischemic injury, KCNH6 expression and function may be altered, affecting neuronal survival.
Migraine: Given the gastrointestinal and neuronal expression of KCNH6, it may be relevant to migraine pathophysiology, though this is speculative. @ Mendelsohn2019
KCNH6 represents a potential therapeutic target for gastrointestinal motility disorders. Modulators of KCNH6 could potentially:
The therapeutic potential of KCNM6 modulation in neurodegenerative diseases is far less clear. If future research confirms a role for KCNH6 in AD, PD, or other conditions, targeting it could represent a novel approach. However, much more research is needed before this becomes a realistic possibility.
Significant questions remain about KCNH6 function. The precise neuronal functions of KCNH6 require further investigation. The role of KCNH6 in specific neurodegenerative diseases needs more rigorous testing. Better tools for studying KCNH6 would facilitate progress.
New approaches are enabling progress on KCNH6 research. Structural studies are revealing the molecular basis of KCNH6 gating. Human genetics is identifying disease-associated variants. These approaches promise to advance understanding of KCNH6 biology and disease relevance.